georgia cancer Center

Augusta, Georgia 30912

3 studies enrolling now · 11 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Solid Tumors, Blood Cancer, COVID-19, Cancer, Carcinoma, Chronic Lymphocytic Leukemia (CLL), Cutaneous T-cell Lymphoma (CTCL), DLBCL, Endometrial Cancer, Follicular Lymphoma, Graft Versus Host Disease

Studies at this site

• Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
• A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types — Recruiting now
• Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease — Recruiting now
• Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. — Completed
• A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies — Running, not enrolling
• Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors — Completed
• Actuate 1901: 9-ING-41 in Myelofibrosis — Completed
• TL-895 and KRT-232 Study in Acute Myeloid Leukemia — Status unconfirmed
• A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes — Stopped early
• A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer — Completed
• A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD — Stopped early